NH TherAguix Competitors and Similar CompaniesClear all
NH TherAguix's competitors and similar companies include Shanghai Henlius Biotech and Elicio Therapeutics.
 NH TherAguix NH TherAguix is a clinical stage company, specializing in nanomedicine for cancer radiotherapy. |  Shanghai Henlius Biotech Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
|  Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. | |
Founding Date | Founding Date 2015 | Founding Date 2009 | Founding Date 2011 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Villeurbanne, FR HQ | Locations HQ | Locations Cambridge, US HQ |
Employees | Employees 1910% decrease | Employees 1273% increase | Employees 22 |
Funding | |||
Latest funding round | Latest funding round $ 14.6m (about 7 years ago) | Latest funding round $ 156m (almost 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 14.6m | Total funding raised $ 346m | Total funding raised $ 150.3m |
For sources of this data, please see the company profile
View Company Profiles
Shanghai Henlius Biotech
HQ
Employees
127↑ 3% increase
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
View companyElicio Therapeutics
HQ
Cambridge, US
Employees
22
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View company